Not a good buy right now for an impatient trader: the stock just surged +9.7% into nearby resistance (168–176) and is showing near-overbought short-term momentum.
With earnings on 2026-02-17 (pre-market), the setup is event-risk heavy; options imply elevated uncertainty (high IV percentile), which can punish a late chase if guidance disappoints.
Sentiment (analysts + options positioning) is bullish, but recent fundamentals show profit/margin compression despite strong revenue growth—this is not an ideal “buy immediately after a spike” profile.
Price action: strong one-day breakout (+9.73% regular session), but post-market slipped (-2.0%), hinting at some immediate profit-taking.
RSI(6) ~69.8: close to overbought; risk of short-term mean reversion after the sharp move.
MACD histogram -0.515 and negatively contracting: bearish momentum is fading, but not yet a clean bullish MACD regime.
Moving averages converging: suggests a transition zone (no strong trend confirmation).
Key levels: Pivot ~156.46; Resistance R1 ~168.34 (price is pressing it), R2 ~175.67 (next upside target). Support S1 ~144.58.
Pattern-based forward odds provided: modest expected drift near-flat short-term, with a slightly negative 1-month bias (-2.6%).
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/skew: Put/Call OI ratio 0.53 and Put/Call volume ratio 0.06 = call-heavy sentiment (bullish/speculative tone).
Volatility: 30D IV ~62.6 vs historical vol ~47.7; IV percentile ~70.9 indicates elevated implied risk premium going into the catalyst (earnings).
Liquidity/flow today: very low absolute option volume (36 total; 34 calls vs 2 puts); not a broad-based flow confirmation despite bullish ratios.
Takeaway: sentiment leans bullish, but elevated IV suggests the market expects a bigger move around earnings—directional chasing after a spike is less attractive.
Technical Summary
Sell
4
Buy
11
Positive Catalysts
supports shareholder-return narrative.
Macro/industry framing from analysts: benefits anticipated from lower rates and improving non-residential indicators.
Overall: growth is strong, but the trend in margins/earnings is currently negative—fundamentals are not cleanly supportive for buying immediately after a large run-up.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: ratings are consistently bullish (Overweight/Buy) with multiple price target increases from late 2025 into Jan 2026.
Notable updates:
Barclays (2026-01-23): Overweight, PT raised to $175 (from $160).
Wells Fargo (2026-01-23): Overweight, PT raised to $189 (from $170).
KeyBanc (2025-12-16): upgraded to Overweight, PT $200.
Citi (2025-12-11): Buy, PT raised to $170 (from $160).
Wall Street pros: constructive cycle view, secular mega-project tailwinds, potential utilization improvements and better cash conversion.
Wall Street cons (implied by cautious outlook language): conservative 2026 outlooks expected; execution/integration and margin recovery must show up in earnings to justify higher targets.
Upside vs targets: with price ~165–169, there’s some upside to $175–$200 targets, but the stock is already moving toward the lower end of that range after the spike—risk/reward is less compelling right now.
People Also Watch
Wall Street analysts forecast HRI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HRI is 175 USD with a low forecast of 150 USD and a high forecast of 200 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast HRI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HRI is 175 USD with a low forecast of 150 USD and a high forecast of 200 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
1 Hold
1 Sell
Moderate Buy
Current: 172.310
Low
150
Averages
175
High
200
Current: 172.310
Low
150
Averages
175
High
200
Barclays
Adam Seiden
Overweight
maintain
$160 -> $175
AI Analysis
2026-01-23
Reason
Barclays
Adam Seiden
Price Target
$160 -> $175
AI Analysis
2026-01-23
maintain
Overweight
Reason
Barclays analyst Adam Seiden raised the firm's price target on Herc Holdings to $175 from $160 and keeps an Overweight rating on the shares. The firm adjusted targets in the machinery and construction group as part of a Q4 preview. Companies benefiting from interest rate cuts "still reign supreme," the analyst tells investors in a research note. Barclays anticipates "conservative" initial outlooks for 2026.
Wells Fargo
Overweight
maintain
$170 -> $189
2026-01-23
Reason
Wells Fargo
Price Target
$170 -> $189
2026-01-23
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Herc Holdings to $189 from $170 and keeps an Overweight rating on the shares. The firm reiterates its positive outlook for the Machinery, Industrials & Environmental Services space heading into earnings. Wells argues the Machinery supply-driven recovery is broadening to new equipment, non-residential lead indicators are accelerating, and cash conversion is improving.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HRI
